India's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...

AstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...

India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...

Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...

Authorities are implementing drastic measures, including isolating exam setters, following NEET paper leaks. While understandable, these ac...

India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...

India's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...

India's top drug regulator is cracking down on veterinary shops. This action follows a significant rejection of shrimp exports to major mar...

Jammu and Kashmir Lt Governor Manoj Sinha declared a strong stance against narco-terrorists. He asserted that those involved in drug traffi...

India's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...

India's Consumer Affairs Ministry is set to develop advanced, machine-readable standards using AI. This initiative aims to simplify complia...

President Trump announced an executive order to shut down and seize funds from bank accounts supporting illegal immigration or holding welf...

The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...

The Enforcement Directorate conducted raids across Maharashtra and Gujarat. The probe targets Mohammad Salim Dola, an alleged drug traffick...

Wockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...

Wockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...

Wockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...